Abstract
Chagas disease (American trypanosomiasis) is one of the most important parasitic diseases with serious social and economic impacts mainly in Latin America. Therefore Chagas’ disease treatment is still a challenge, mainly in Brazil, where the only commercially available drug is benznidazole (Rochagan®). Since 1984, the WHO has recommended the use of crystal violet (gentian violet) in blood banks in endemic areas to prevent transmission by transfusion.
Keywords: QSAR-3D, CoMFA, Chaga´s Disease.
Related Journals
Current Computer-Aided Drug Design
Combinatorial Chemistry & High Throughput Screening
Current Drug Delivery
Current Bioactive Compounds
Current Drug Safety
Reviews on Recent Clinical Trials
Drug Delivery Letters
Recent Advances in Drug Delivery and Formulation
Recent Advances in Anti-Infective Drug Discovery
Drug Metabolism and Bioanalysis Letters
Related Books
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Biopolymers In Drug Delivery: Recent Advances and Challenges
Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms
Current Technologies To Increase The Transdermal Delivery Of Drugs